Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Solid Biosciences Inc. | sldb-ex322_11.htm |
| EX-32.1 - EX-32.1 - Solid Biosciences Inc. | sldb-ex321_10.htm |
| EX-31.2 - EX-31.2 - Solid Biosciences Inc. | sldb-ex312_12.htm |
| EX-31.1 - EX-31.1 - Solid Biosciences Inc. | sldb-ex311_16.htm |
| EX-21.1 - EX-21.1 - Solid Biosciences Inc. | sldb-ex211_192.htm |
| EX-10.27 - EX-10.27 - Solid Biosciences Inc. | sldb-ex1027_193.htm |
| EX-10.26 - EX-10.26 - Solid Biosciences Inc. | sldb-ex1026_198.htm |
| EX-10.25 - EX-10.25 - Solid Biosciences Inc. | sldb-ex1025_199.htm |
| EX-10.24 - EX-10.24 - Solid Biosciences Inc. | sldb-ex1024_200.htm |
| EX-4.2 - EX-4.2 - Solid Biosciences Inc. | sldb-ex42_197.htm |
| 10-K - 10-K - Solid Biosciences Inc. | sldb-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-222763) and Form S-3 (No. 333-233594 and No. 333-230228) of Solid Biosciences Inc. of our report dated March 10, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 12, 2020